← Leaderboards
Monica Bessler
Barnes-Jewish Hospital
$11,468,538
Attributed
$11,468,538
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–14$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$11,468,538 · 11
By mechanism
R01$10,624,137 · 5
R21$811,063 · 2
P41$33,338 · 4
Top collaborators
No co-investigators on record.
Most similar at Barnes-Jewish Hospital
Same institution · by research overlap
- George J Broze$10,705,919
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularLeadFunctional DisorderHematopoietic Stem CellsProteinsDiagnosisMutationGlycosylphosphatidylinositolsHematopoiesisInheritedCellsGenesMutantSyndromeLaboratory MouseBlood CellsErythrocytesProteomicsPhenotypeBiomarkerComplementInvestigationGene MutationMonitor
Grant awards (36)
MOLECULAR STUDIES OF BONE MARROW FAILURE$561,426
R01 · FY2014 · CA · contact PI
MOLECULAR STUDIES OF BONE MARROW FAILURE$544,060
R01 · FY2013 · CA · contact PI
CHANGES IN THE RBC PROTEOME DURING HEALTH AND DISEASE$325,670
R01 · FY2013 · DK · contact PI
CHANGES IN THE RBC PROTEOME DURING HEALTH AND DISEASE$123,489
R01 · FY2013 · DK · contact PI
MOLECULAR STUDIES OF BONE MARROW FAILURE$578,787
R01 · FY2012 · CA · contact PI
CHANGES IN THE RBC PROTEOME DURING HEALTH AND DISEASE$337,548
R01 · FY2012 · DK · contact PI
MOLECULAR STUDIES OF BONE MARROW FAILURE$584,050
R01 · FY2011 · CA · contact PI
CHANGES IN THE RBC PROTEOME DURING HEALTH AND DISEASE$337,610
R01 · FY2011 · DK · contact PI
DIFFERENCES IN THE PROTEIN SIGNATURES/PNH PLATELETS$4,042
P41 · FY2011 · RR · contact PI
MOLECULAR STUDIES OF BONE MARROW FAILURE$541,473
R01 · FY2010 · CA · contact PI
CHANGES IN THE RBC PROTEOME DURING HEALTH AND DISEASE$427,816
R01 · FY2010 · DK · contact PI
DIFFERENCES IN THE PROTEIN SIGNATURES/PNH PLATELETS$14,575
P41 · FY2010 · RR · contact PI
DIFFERENCES IN THE PROTEIN SIGNATURES/PNH PLATELETS$8,730
P41 · FY2009 · RR · contact PI
Telomeres and Ribosomes in Dyskeratosis Congenita$362,679
R01 · FY2008 · HL · contact PI
DIFFERENCES IN THE PROTEIN SIGNATURES/PNH PLATELETS$5,991
P41 · FY2008 · RR · contact PI
Molecular Studies of Bone Marrow Failure$514,833
R01 · FY2007 · CA · contact PI
Telomeres and Ribosomes in Dyskeratosis Congenita$362,679
R01 · FY2007 · HL · contact PI
Ribosome Biogenesis in Diamond Blackfan Anemia$184,490
R21 · FY2007 · DK · contact PI
Protein Signatures of Normal versus Paroxysmal Nocturnal Hemoglobinuria Platelets$184,490
R21 · FY2007 · HL · contact PI
Molecular Studies of Bone Marrow Failure$515,516
R01 · FY2006 · CA · contact PI
Telomeres and Ribosomes in Dyskeratosis Congenita$373,511
R01 · FY2006 · HL · contact PI
Differences in the Protein Signatures/PNH Platelets$226,458
R21 · FY2006 · HL · contact PI
Ribosome Biogenesis in Diamond Blackfan Anemia$215,625
R21 · FY2006 · DK · contact PI
Molecular Studies of Bone Marrow Failure$513,180
R01 · FY2005 · CA
Telomeres and Ribosomes in Dyskeratosis Congenita$382,500
R01 · FY2005 · HL
ROLE OF THE PNH PHENOTYPE IN LEUKEMIC TRANSFORMATION$290,891
R01 · FY2005 · CA
Molecular Studies of Bone Marrow Failure$549,833
R01 · FY2004 · CA
Telomeres and Ribosomes in Dyskeratosis Congenita$382,500
R01 · FY2004 · HL
ROLE OF THE PNH PHENOTYPE IN LEUKEMIC TRANSFORMATION$305,891
R01 · FY2004 · CA
ROLE OF THE PNH PHENOTYPE IN LEUKEMIC TRANSFORMATION$284,237
R01 · FY2003 · CA
ROLE OF THE PNH PHENOTYPE IN LEUKEMIC TRANSFORMATION$15,000
R01 · FY2003 · CA
INACTIVATION OF THE PIGA GENE IN HEMATOPOIETIC STEM CELL$300,184
R01 · FY2002 · HL
ROLE OF THE PNH PHENOTYPE IN LEUKEMIC TRANSFORMATION$284,237
R01 · FY2002 · CA
ROLE OF THE PNH PHENOTYPE IN LEUKEMIC TRANSFORMATION$305,362
R01 · FY2001 · CA
INACTIVATION OF THE PIGA GENE IN HEMATOPOIETIC STEM CELL$284,684
R01 · FY2001 · HL
INACTIVATION OF THE PIGA GENE IN HEMATOPOIETIC STEM CELL$234,491
R01 · FY2000 · HL